Clinical Trials Browser

Interventional × Glucose × 1 year × Clear all

NCT07473128 2026-03-16

Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer

Phase 3 Not yet recruiting

120 enrolled

Thoracic

Limited Stage Small Cell Lung Cancer

NCT04895358 2026-03-11

KEYNOTE-B49

Phase 3 Active not recruiting

340 enrolled

Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms, Neoplasm Metastasis

NCT05116189 2026-03-09

KEYNOTE-B96

Phase 3 Active not recruiting

643 enrolled 17 charts 1 FDA

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02253316 2025-11-10

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Phase 2 Active not recruiting

236 enrolled 13 charts

Plasma cell

Multiple Myeloma

NCT07091864 2025-11-10

Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma

Phase NA Recruiting

116 enrolled

CNS

Glioblastoma

NCT06855628 2025-10-28

Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

Phase 2 Suspended

10 enrolled

CNS

Glioma

NCT03740165 2025-10-22

KEYLYNK-001

Phase 3 Active not recruiting

1,367 enrolled 29 charts

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT06391099 2025-09-30

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Phase NA Recruiting

60 enrolled

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT05933577 2025-09-24

V940-001

Phase 3 Active not recruiting

1,089 enrolled

Dermatologic

Melanoma